These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3008680)

  • 1. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain.
    Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M
    Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680
    [No Abstract]   [Full Text] [Related]  

  • 2. A stage model of HTLV-III LAV infection in intravenous drug users.
    Des Jarlais DC; Friedman SR; Spira TJ; Zolla-Pazner S; Marmor M; Holzman R; Mildvan D; Yancovitz S; Mathur-Wagh U; Garber J
    NIDA Res Monogr; 1986; 67():328-34. PubMed ID: 3018574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area].
    Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M
    Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic generalized lymphadenopathy with splenomegaly associated with HTLV-III virus antibodies].
    Mijović A; Stevanović G; Brkić S; Dimitrijević M; Rolović Z; Ruvidić R
    Srp Arh Celok Lek; 1986 Jan; 114(1):109-20. PubMed ID: 3014667
    [No Abstract]   [Full Text] [Related]  

  • 5. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human T-lymphotropic virus (HTLV-III) antibodies in intravenous drug addicts from the Valencia community].
    Rodrigo JM; Serra MA; Aguilar E; Ample I; Gimeno V; del Olmo JA; Escudero A; Aparisi L; Wassel A; Sanmartín B
    Med Clin (Barc); 1986 Jan; 86(3):89-92. PubMed ID: 3007886
    [No Abstract]   [Full Text] [Related]  

  • 7. [Seropositivity against antigens of the HTLV-III lymphotropic virus in different communities from the Barcelona area].
    Barrera Sala JM; Ercilla MG; Gelabert A; Castillo R
    Med Clin (Barc); 1986 Jan; 86(3):129-30. PubMed ID: 3007882
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
    De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
    Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HTLV-III in hemophilic patients in Barcelona].
    Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
    Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].
    Pineda JA; Leal M; García de Pesquera F; Sánchez-Quijano A; Rivera F; Lissen E
    Med Clin (Barc); 1986 Mar; 86(12):498-500. PubMed ID: 3012223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
    Robert-Guroff M; Weiss SH; Giron JA; Jennings AM; Ginzburg HM; Margolis IB; Blattner WA; Gallo RC
    JAMA; 1986 Jun; 255(22):3133-7. PubMed ID: 3009910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 17. HTLV-III antibody in Swiss and English intravenous drug abusers.
    Mortimer PP; Vandervelde EM; Jesson WJ; Pereira MS; Burkhardt F
    Lancet; 1985 Aug; 2(8452):449-50. PubMed ID: 2863476
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies to AIDS-associated retrovirus (HTLV-III/LAV) in drug addicts from Vizcaya, northern Spain.
    Merino F; Esparza B; Aizpiri J; Fernandez J; de Masdelval L; Arrieta A; Velazquez M; Volsky DJ; San Cristobal E; de Izaguirre A
    AIDS Res; 1986; 2(2):133-40. PubMed ID: 3013221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-III antibodies in drug addicts in Spain.
    Rodrigo JM; Serra MA; Aguilar E; del Olmo JA; Gimeno V; Aparisi L
    Lancet; 1985 Jul; 2(8447):156-7. PubMed ID: 2862347
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.